College Point, New York Clinical Trials

A listing of College Point, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 407 clinical trials
Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System - INFINITE-US

Prospective, non-randomized, multicenter pre-market early feasibility study (EFS) to evaluate subjects treated with the BlueLeaf System for the treatment of symptomatic CVI of the lower extremity

NYU Langone Medical Center
 (7.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Dynamically Tailored Behavioral Interventions in Diabetes

In this project, the investigators will evaluate the efficacy of a novel approach to personalizing behavioral interventions for self-management of type 2 diabetes (T2DM) to individuals' behavioral and glycemic profiles discovered using computational learning and self-monitoring data. This study is a two-arm randomized controlled trial with n=280 participants recruited from …

behavior modification
self monitoring
Columbia University Irving Medical Center
 (6.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Accelerometer Sensing for Micra AV Study

The purpose of the AccelAV Study is to characterize chronic AV synchrony in subjects implanted with MicraTM AV device. This study will be conducted upon market approval of the MicraTM AV Transcatheter Pacing System.

atrioventricular block
NYU Langone Medical Center
 (7.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC.

cancer
metastatic castration-resistant prostate cancer
metastatic hormone refractory prostate cancer
rimiducid
metastatic disease
Memorial Sloan Kettering Cancer Center
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Lorenc Aesthetic Plastic Surgery Center
 (5.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
GutMe!: IBS and Collagen Protein Powder an Interventional Study

In this study we would like to understand how or if a food-based supplement affects gut symptoms such as bloating, stomach cramps and irregular bowel habits. Through using a digital symptom tracking app for a few weeks, you may just learn more about exactly what is triggering your symptoms!

spasm
bloating
gut symptoms
ProofPilot (Virtual Study: https://p.proofpilot.com)
 (8.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

This is an open-label, dose escalation study to evaluate the safety, toxicity, and pharmacokinetics (PK) as well as preliminary efficacy of BTX-A51 capsules in participants with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). The study will be done in two phases. Phase 1a of this …

exhaustion
acute myeloid leukemia
leukemia
refractory acute myeloid leukemia (aml)
cancer therapy
Memorial Sloan-Kettering Cancer Center
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas

The blood brain barrier (BBB) prevents some drugs from successfully reaching the target source. Convection-Enhanced Delivery (CED) is a method of direct infusion of drugs under controlled pressure to the tumor that may reduce systemic side effects of drugs in the patient. The purpose of this Phase I study is …

side effects of drugs
glioma
epilepsy
seizures
anesthesia
Columbia University Irving Medical Center
 (6.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment

A Phase1/2a Study of Rigosertib plus Nivolumab in Stage IV Lung Adenocarcinoma Patients with KRAS Mutation who Progressed on First-Line Treatment

metastatic lung adenocarcinoma
adenocarcinoma
kras
hysterectomy
oophorectomy
Icahn School of Medicine at Mount Sinai
 (5.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
ATR Inhibitor BAY 1895344 Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

The purpose of the study is to test how well patients with advanced solid tumors and ovarian cancer respond to treatment with BAY1895344 in combination with niraparib. In addition researchers want to find for patients the optimal dose of BAY1895344 in combination with niraparib, how the drug is tolerated and …

ATR
peritoneal cancer
tumor cells
muga scan
fallopian tube
Memorial Sloan-Kettering Cancer Center
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations